Skip to main content

Advertisement

SpringerLink
Log in

Co-expression Network Analysis Revealing the Potential Regulatory Roles of lncRNAs in Alzheimer’s Disease

  • Original Research Article
  • Published:
Interdisciplinary Sciences: Computational Life Sciences Aims and scope Submit manuscript

Abstract

Alzheimer’s disease (AD) is one of the most common types of dementia among the elderly. Previous studies had revealed that the dysregulation of lncRNAs played important roles in human diseases, including AD. However, there is still a lack of comprehensive analysis of differently expressed long non-coding RNAs (lncRNAs) in different distinct regions related to AD. In present study, we identified a total of 678, 593, 941, 1445, 1179, 466 differently expressed lncRNAs that were found in entorhinal cortex (EC), middle temporal gyrus(MTG), hippocampus (HIP), superior frontal gyrus (SFG), posterior cingulate (PC), cortex and primary visual cortex (VCX) AD samples, respectively. Furthermore, we constructed lncRNA–mRNA co-expression networks in AD to explore the potential roles of these lncRNAs. Differentially expressed (DE) lncRNAs were involved in regulating metabolic process, respiratory electron transport chain and ATP metabolic process showed by GO analysis. Interestingly, KEGG analysis revealed these lncRNAs were associated with neurodegenerative disorders such as Alzheimer’s disease, Huntington’s disease and Parkinson’s disease. Four lncRNAs (LOC100507557, LOC101929787, NEAT1, and JAZF1-AS1) were identified as key lncRNAs in AD progression and dysregulated in different distinct regions related to AD. Our study has uncovered several key lncRNAs in AD, which would give novel underlying therapeutic and prognostic targets for AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Li J, Xuan Z, Liu C (2013) Long non-coding RNAs and complex human diseases. Int J Mol Sci 14(9):18790–18808

    Article  CAS  Google Scholar 

  2. Zhang A, Xu M, Mo YY (2014) Role of the lncRNA-p53 regulatory network in cancer. J Mol Cell Biol 6(3):181–191

    Article  Google Scholar 

  3. Liu JY et al (2014) Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis 5:e1506

    Article  CAS  Google Scholar 

  4. Xing D et al (2014) Identification of long noncoding RNA associated with osteoarthritis in humans. Orthop Surg 6(4):288–293

    Article  Google Scholar 

  5. Chuang TD, Khorram O (2018) Expression Profiling of lncRNAs, miRNAs, and mRNAs and their differential expression in leiomyoma using next-generation RNA sequencing. Reprod Sci 25(2):246–255

    Article  CAS  Google Scholar 

  6. Zhang B et al (2014) A novel RNA motif mediates the strict nuclear localization of a long noncoding RNA. Mol Cell Biol 34(12):2318–2329

    Article  Google Scholar 

  7. Zhou X et al (2015) The interaction between MiR-141 and lncRNA-H19 in regulating cell proliferation and migration in gastric cancer. Cell Physiol Biochem 36(4):1440–1452

    Article  Google Scholar 

  8. Wu G et al (2014) LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity. Circulation 130(17):1452–1465

    Article  CAS  Google Scholar 

  9. Gonzalez I et al (2015) A lncRNA regulates alternative splicing via establishment of a splicing-specific chromatin signature. Nat Struct Mol Biol 22(5):370–376

    Article  CAS  Google Scholar 

  10. Wan G et al (2014) Noncoding RNAs in DNA repair and genome integrity. Antioxid Redox Signal 20(4):655–677

    Article  CAS  Google Scholar 

  11. Ubhi K, Masliah E (2013) Alzheimer’s disease: recent advances and future perspectives. J Alzheimers Dis 33(Suppl 1):S185–S194

    PubMed  Google Scholar 

  12. Lukiw WJ et al (2012) Studying micro RNA function and dysfunction in Alzheimer’s Disease. Front Genet 3:327

    Article  Google Scholar 

  13. Rijal UA et al (2014) Biochemical stages of amyloid-beta peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer’s disease. Brain 137(Pt 3):887–903

    Article  Google Scholar 

  14. Nie J et al (2016) Dendrobium alkaloids prevent Abeta25-35-induced neuronal and synaptic loss via promoting neurotrophic factors expression in mice. PeerJ 4:e2739

    Article  Google Scholar 

  15. Cirillo C et al (2015) S100B inhibitor pentamidine attenuates reactive gliosis and reduces neuronal loss in a mouse model of Alzheimer’s disease. Biomed Res Int 508342

  16. Gu C et al (2018) Long noncoding RNA EBF3-AS promotes neuron apoptosis in Alzheimer’s disease. DNA Cell Biol

  17. Zhou X, Xu J (2015) Identification of Alzheimer’s disease-associated long noncoding RNAs. Neurobiol Aging 36(11):2925–2931

    Article  CAS  Google Scholar 

  18. Liang WS et al (2007) Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. Physiol Genomics 28(3):311–322

    Article  CAS  Google Scholar 

  19. Liang WS et al (2008) Alzheimer’s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci USA 105(11):4441–4446

    Article  CAS  Google Scholar 

  20. Wettenhall JM, Smyth GK (2004) limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics 20(18):3705–3706

    Article  CAS  Google Scholar 

  21. Gallon S, Loubes JM, Maza E (2013) Statistical properties of the quantile normalization method for density curve alignment. Math Biosci 242(2):129–142

    Article  Google Scholar 

  22. Lam B et al (2013) Clinical, imaging, and pathological heterogeneity of the Alzheimer’s disease syndrome. Alzheimers Res Ther 5(1):1

    Article  Google Scholar 

  23. Patel A et al (2011) Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer’s disease in subjects with Down syndrome. Neurosci Lett 487(2):144–148

    Article  CAS  Google Scholar 

  24. Shi X et al (2013) Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 339(2):159–166

    Article  CAS  Google Scholar 

  25. Fang M et al (2017) Bioinformatics and co-expression network analysis of differentially expressed lncRNAs and mRNAs in hippocampus of APP/PS1 transgenic mice with Alzheimer disease. Am J Transl Res 9(3):1381–1391

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Imamura K et al (2014) Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli. Mol Cell 53(3):393–406

    Article  CAS  Google Scholar 

  27. Chakravarty D et al (2014) The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat Commun 5:5383

    Article  CAS  Google Scholar 

  28. Wang Y et al., C/EBPbeta contributes to transcriptional activation of long non-coding RNA NEAT1 during APL cell differentiation. Biochem Biophys Res Commun, 2017

  29. Wang Q et al (2017) NEAT1/miR-181c regulates osteopontin (OPN)-mediated synoviocyte proliferation in osteoarthritis. J Cell Biochem 118(11):3775–3784

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Zhejiang Hospital, Hangzhou, 310000, Zhejiang, China

    Jiong Wu, Linhui Chen, Chaobo Zheng, Shanhu Xu, Yuhai Gao & Junjun Wang

Authors
  1. Jiong Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Linhui Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chaobo Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shanhu Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuhai Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Junjun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conception and design: JW; JJW; development of methodology: LHC; CBZ; analysis and interpretation of data: SHX; YHG; writing, review, and/or revision of manuscript: JW; LHC; JJW.

Corresponding author

Correspondence to Junjun Wang.

Ethics declarations

Conflict of Interest

The authors declare that they have no competing interests.

Ethical Approval

This article does not contain any studies with human participants performed by any of the authors.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary Table 1

Co-expression network analysis related to Figure 2. (XLSX 430 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, J., Chen, L., Zheng, C. et al. Co-expression Network Analysis Revealing the Potential Regulatory Roles of lncRNAs in Alzheimer’s Disease. Interdiscip Sci Comput Life Sci 11, 645–654 (2019). https://doi.org/10.1007/s12539-019-00319-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12539-019-00319-w

Keywords

Search

Navigation